Some pieces of evidence have shown that improvements in systemic glucose homeostasis and insulin sensitivity account for the rapid effect of MSB on the remission of hepatic steatosis [6, 7], but investigations of lipid alterations in the early postoperative recovery phase are still lacking. The gene discussed is INS; the disease is Hepatic steatosis.